Get the Stockscreener App
1.13
2.73%
0.03
Pre-market:
1.18
0.05
+4.42%
Vivani Medical Inc stock is traded at $1.13, with a volume of 203.92K.
It is up +2.73% in the last 24 hours and down -3.42% over the past month.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
See More
Previous Close:
$1.10
Open:
$1.17
24h Volume:
203.92K
Relative Volume:
0.86
Market Cap:
$97.45M
Revenue:
-
Net Income/Loss:
$-27.09M
P/E Ratio:
-2.7998
EPS:
-0.4036
Net Cash Flow:
$-26.52M
1W Performance:
-1.74%
1M Performance:
-3.42%
6M Performance:
-16.30%
1Y Performance:
-1.74%
1-Day Range:
$1.10
$1.19
1-Week Range:
$1.10
$1.19
52-Week Range:
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
415-506-8462
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.13 | 97.45M | 0 | -27.09M | -26.52M | -0.4036 |
VRTX
Vertex Pharmaceuticals Inc
|
450.46 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
614.98 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
884.20 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
287.80 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
160.06 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vivani Medical Inc Stock (VANI) Latest News
VANI Q1 2026 Earnings: Narrowed Loss Beat Estimates, Stock Slips Despite ProgressAnalyst Earnings Estimate - newsline.com
VANI Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Stock DeclineEBITDA Margin Trends - newsline.com
Vivani Medical (VANI) Holds Near Support After Slight DeclineForce Index - newsline.com
VANI Q1 2026 Earnings: Narrower-than-expected loss highlights clinical progress in obesity pipelineRevenue Beat Analysis - newsline.com
VANI Stock Price, Quote & Chart - ChartMill
Vivani Medical (VANI) Slips 2.54% as Stock Tests Key Support at $1.09Aggressive Growth Picks - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss and Pipeline Progress Amidst Stock DeclineProduct Revenue Analysis - newsline.com
Vivani Medical Inc. (VANI) Q1 2026 Earnings: Narrower-Than-Expected Loss as Clinical Preparations Continue - newsline.com
VANI News | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill
Vivani Medical Highlights Investor Presentation at Jefferies Conference - TipRanks
Vivani to Present CEO Slide Deck at Jefferies Global Healthcare Conference - TradingView
Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 - markets.businessinsider.com
VANI Q1 2026 Earnings: Narrower Than Expected Loss Drives Positive Stock ReactionPost-Earnings Drift - newsline.com
Vivani Medical Q1 2026 Earnings: Slight EPS Beat Signals Progress Despite No RevenueUpward Estimate Revision - The Legal Advocate
Vivani Medical Q1 2026 Earnings: Narrower Net Loss Surpasses ExpectationsMargin Compression Risk - Newser
Vivani Medical (VANI) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionProfit Announcement - newsline.com
Vivani Medical Q1 2026 Earnings: Slight EPS Beat Fails to Stem Stock Decline as Pre-Revenue Biotech Navigates Development PipelineExpert Trade Signals - Newser
Vivani Medical director Gregg Williams buys $2m in common stock - Investing.com
Vivani Medical Insider Bought Shares Worth $1,999,999, According to a Recent SEC Filing - Moomoo
Here's Why We're Watching Vivani Medical's (NASDAQ:VANI) Cash Burn Situation - Yahoo Finance
Vivani Medical (VANI) price target increased by 10.00% to 5.61 - MSN
Vivani Medical 1Q Loss/Shr 8c >VANI - Moomoo
Vivani Medical 1Q Loss $6.78M >VANI - Moomoo
Vivani Highlights Q1 Progress on Semaglutide Implant Program - TipRanks
Vivani Medical Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Vivani Medical, Inc. 1Q 2026: Net income $(6.78M), EPS $(0.08) — 10-Q Summary - TradingView
Vivani Medical: Q1 Earnings Snapshot - marketscreener.com
Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - marketscreener.com
TradingKey - TradingKey
Vivani Medical Insider Ups Holding By 17% During Year - simplywall.st
Number of shareholders of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical (VANI) to Release Quarterly Earnings on Tuesday - MarketBeat
VANI Fundamental Analysis & Valuation | Fair Value & Financial Strength | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill
Vivani (VANI) Stock: Is It Worth Allocating Capital | Q4 2025: Better Than ExpectedExpert Breakout Alerts - newser.com
VANI (Vivani) posts narrower than expected Q4 2025 loss, shares gain over three percent in daily trading.Trending Social Stocks - newser.com
VANI Technical Analysis | Trend, Signals & Chart Patterns | VIVANI MEDICAL INC (NASDAQ:VANI) - ChartMill
AI Models See Vivani Medical as a High-Risk Momentum Play After Capital Raise - TipRanks
VANI SEC FilingsVivani Medical 10-K, 10-Q, 8-K Forms - Stock Titan
Williams Gregg buys Vivani medical (VANI) shares worth $1.99m - Investing.com
Insider Stock Purchases: April 16, 2026 - Moomoo
Vivani Medical (NASDAQ:VANI) Director Gregg Williams Acquires 1,587,301 Shares - MarketBeat
Vivani (VANI) Stock: Strengthening? (Parabolic) 2026-04-16Low Risk Entry - Cổng thông tin điện tử tỉnh Lào Cai
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.40%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):